Recombinant somatropin

Indications

Growth disturbances caused by insufficient secretion of endogenous growth hormones or by gonadal dysgenesis (turner’s syndrome)

Dosage

Individual generally 0.5-0.7 i.u./kg body wt per week (or higher doses as judged) div. into 6-7 subcutaneous injection recommended. Turner’s syndrome 1 i.u./kg body wt recommended.

Special Precautions

Diabetes mellitus. In growth hormone deficiency secondary to treatment of malignant disease, pay attention to signs of relapseof malignancy.

Drug Interactions

Antagonism with insulin.